Publications

Jacquemot, C., Dupoux, E., Pallier, C. & Bachoud-Levi, A. (2002). Comprehending spoken words without hearing phonemes: A case study. Cortex, 38, 869-873

De Diego-Balaguer, R., Schramm, C., Rebeix, I., Dupoux, E., Durr, A., Brice, A., Charles, P., Cleret de Langavant, L., Youssov, K., Verny, C., Damotte, V., Azulay, J., Goizet, C., Simonin, C., Tranchant, C., Maison, P., Rialland, A., Schmitz, D., Jacquemot, C., Fontaine, B. & Bachoud-Levi, A. (2016 ). COMT Val158Met} Polymorphism Modulates Huntington's Disease Progression. Plos One, 11(9), e0161106. doi:10.1371/journal.pone.0161106

Désaméricq, G., Dolbeau, G., Verny, C., Charles, P., Durr, A., Youssov, K., Simonin, C., Azulay, J., Tranchant, C., Goizet, C., Damier, P., Broussolle, E., Démonet, J., Morgado, G., Cleret de Langavant, L., Macquin-Mavier, I., Bachoud-Levi, A. & Maison, P. (2014). Effectiveness of anti-psychotics and related drugs in the Huntington French-speaking group cohort. PloS one, 9(1), e85430. doi:10.1371/journal.pone.0085430

Hugues, A., Guinet-Lacoste, A. , Bin, S. , Lunven, M., Pérennou, D. , Giraux, P. , Foncelle, A. , Rossetti, Y., Jacquin-Courtois, S., Luauté, J. & Rode, G. (2021). Effects of prismatic adaptation on balance and postural disorders in patients with chronic right stroke: protocol for a multicentre double-blind randomised sham-controlled trial. BMJ Open , 11(11), e052086. doi:10.1136/bmjopen-2021-052086

Trinkler, I., Devignevielle, S., Achaibou, A., Ligneul, R., Brugières, P., Cleret de Langavant, L., De Gelder, B., Scahill, R., Schwartz, S. & Bachoud-Levi, A. (2017). Embodied emotion impairment in Huntington's Disease. Cortex; a journal devoted to the study of the nervous system and behavior, 92, 44-56. doi:10.1016/j.cortex.2017.02.019

Gallezot, C. , Riad, R., Titeux, H., Lemoine, L., Montillot, J., Sliwinski, A., Hamet Bagnou, J., Cao, X., Youssov, K., Dupoux, E. & Bachoud-Levi, A. (2022). Emotion expression through spoken language in Huntington Disease. Cortex. doi:10.1016/j.cortex.2022.05.024

Martín-Gómez, C., Darío Ortigoza-Escobar, J., Nou-Fontanet, L., M Molina-Linde, J., Bachoud-Levi, A., Léger, J., Antonio Blasco-Amaro, J. & Disorders Guideline Working Group, N. (2023). Exploring the values, preferences, and information needs of patients with NKX2-1-related disorders: A qualitative study protocol. PloS one, 18(2), e0281573. doi:10.1371/journal.pone.0281573

Van Der Gucht, A., Aoun-Sebaiti, M., Kauv, P., Guedj, E., Aouizerate, J., Verger, A., Gherardi, R., Bachoud-Levi, A., Authier, F. & Itti, E. (2016). FDG-PET/CT Brain Findings in a Patient With Macrophagic Myofasciitis. Nuclear medicine and molecular imaging, 50(1), 80-4. doi:10.1007/s13139-015-0371-z

Matthys, A., Seddik, L. , Djellaoui, A. , Faugeras, F., Abdelhedi, J. , Petit, A. , Boyer, J. , Montillot, J., Hosseini, H. & Bachoud-Levi, A. (2020). Forme inflammatoire d’angiopathie amyloïde : à propos d’un cas. Revue Neurologique, 176, S71-S72

Bachoud-Levi, A. (2017). From open to large-scale randomized cell transplantation trials in Huntington's disease: Lessons from the multicentric intracerebral grafting in Huntington's disease trial (MIG-HD) and previous pilot studies. Prog Brain Res. (Vol. 230, pp. 227-261). doi:10.1016/bs.pbr.2016.12.011

Désaméricq, G., Youssov, K., Charles, P., Saleh, N., Olivier, A., Sherer-Gagou, C. & Verny, C. (2016). Guidelines for clinical pharmacological practices in Huntington's disease. Rev Neurol (Paris), 172(8-9), 423-432. doi:10.1016/j.neurol.2016.07.012

Fenelon, G. (2019). Hallucinations visuelles. In Hélène Amievia, Antoinette Prouteau, Olivier Martinaud (Eds.), Neuropsychologie en psychiatrie

Cleret de Langavant, L., Trinkler, I., Cesaro, P. & Bachoud-Levi, A. (2009). Heterotopagnosia: When I point at parts of your body. Neuropsychologia, 47(7), 1745-55. doi:10.1016/j.neuropsychologia.2009.02.016

Villafane, G., Thiriez, C., Audureau, E., Straczek , C., Kerschen, P., Cormier-Dequaire , F., Van Der Gucht, A., Gurruchaga, J., Evangelista, E., Defer, G., Damier, P., Remy, P., Itti, E., Fenelon, G. & Quéré-Carne M, M. (2017). High-dose transdermal nicotine in Parkinson's disease patients: a randomized, open-label, blinded-endpoint evaluation phase 2 study. Eur J Neurol , 25, 120-127. doi:10.1111/ene.13474

Schramm, C., Katsahian, S., Youssov, K., Démonet, J., Krystkowiak, P., Supiot, F., Verny, C., Cleret de Langavant, L. & Bachoud-Levi, A. (2015). How to Capitalize on the Retest Effect in Future Trials on Huntington’s Disease. PLoS ONE. doi:10.1371/journal.pone.0145842

Bachoud-Levi, A., (Et Al), . & Cleret de Langavant, L. (2020). Human Fetal Cell Therapy in Huntington's Disease: A Randomized, Multicenter, Phase II Trial. Movement disorders, 35(8), 1323-1335. doi:10.1002/mds.28201

Moss, D., Pardiñas , A., Langbehn, D., Leavitt, B., Roos, R., Durr, A., Mead, S., Track-Hd, i., Registry, i., Holmans, P., Jones, L., Tabrizi, S. & Bachoud-Levi, A. (2017). Identification of genetic variants associated with Huntington's disease progression: a genome-wide association study. Lancet Neurol., 16(9), 701-711. doi:10.1016/S1474-4422(17)30161-8

Wimberley, C., Lavisse, S., Brulon, V., Peyronneau, M., Leroy, C., Bodini, B., Remy, P., Stankoff, B., Buvat, I. & Bottlaender, M. (2018). Impact of Endothelial 18-kDa Translocator Protein on the Quantification of 18F-DPA-714. J Nucl Med, 59(2), 307-314. doi:10.2967/jnumed.117.195396

Wimberley, C., Lavisse, S., Brulon, V., Peyronneau, M., Kuhnast, B., Leroy, C., Remy, P., Stankoff, B. & Bottlaender, M. (2018). Impact of endothelial TSPO on the quantification of 18F-DPA714 in the normal human brain. , 59(2), 307-314. doi:10.2967/jnumed.117.195396

Bachoud-Levi, A., Dormeuil, A. & Jacquemot, C. (2022). Improving efficacy of aphasia rehabilitation by using Core Assessment of Language Processing. Annals of Physical and Rehabilitation Medicine, 66(6), 101630. doi:10.1016/j.rehab.2022.101630

Jacquemot, C., Lalanne, C., Sliwinski, A., Piccinini, P., Dupoux, E. & Bachoud-Levi, A. (2019). Improving language evaluation in neurological disorders: The French Core Assessment of Language Processing (CALAP). Psychological assessment, 31(5), 622-630. doi:10.1037/pas0000683

Bayen , E., Cleret de Langavant, L., Youssov, K. & Bachoud-Levi, A. (2023). Informal care in Huntington's disease: Assessment of objective-subjective burden and its associated risk and protective factors. Annals of physical and rehabilitation medicine, 66(4), 101703. doi:10.1016/j.rehab.2022.101703

Bachoud-Levi, A., Ferreira, J., Massart, R., Youssov, K., Rosser, A., Busse, M., Craufurd, D., Reilmann, R., De Michele, G., Rae, D., Squitieri, F., Seppi, K., Perrine, C., Scherer-Gagou, C., Audrey, O., Verny, C. & Burgunder, J. (2019). International Guidelines for the Treatment of Huntington's Disease. Frontiers in Neurology, 10, 710. doi:10.3389/fneur.2019.00710

Jacquemot, C., Dupoux, E. & Bachoud-Levi, A. (2011). Is the word-length effect linked to subvocal rehearsal? Cortex, 47(4), 484-493. doi:10.1016/j.cortex.2010.07.007

Trinkler, I., Cleret de Langavant, L. & Bachoud-Levi, A. (2013). Joint recognition-expression impairment of facial emotions in Huntington's disease despite intact understanding of feelings. Cortex; a journal devoted to the study of the nervous system and behavior, 49(2), 549-58. doi:10.1016/j.cortex.2011.12.003

Le Stanc, L., Youssov, K., Giavazzi, M., Sliwinski, A., Bachoud-Levi, A. & Jacquemot, C. (2023). Language disorders in patients with striatal lesions: Deciphering the role of the striatum in language performance. Cortex; a journal devoted to the study of the nervous system and behavior, 166, 91-106. doi:10.1016/j.cortex.2023.04.016

Jacquemot, C. (2022). Le traitement lexico-sémantique dépend-il de ressources exécutives spécifiques au langage ? Revue neurobiologique, Supplément, S180-S181. doi:10.1016/j.neurol.2022.02.116

Riad, R., Karadayi, J., Bachoud-Levi, A. & Dupoux, E. (2021). Learning spectro-temporal representations of complex sounds with parameterized neural networks. The Journal of the Acoustical Society of America, 150, 353. doi:10.1121/10.000548210.1121/10.0005482

Bachoud-Levi, A. (2020). Long before Huntington's disease: what matters most? The Lancet Neurology, 19(6), 473-475. doi:10.1016/S1474-4422(20)30156-3

Cleret de Langavant, L., Sudraud, S., Verny, C., Krystkowiak, P., Simonin, C., Damier, P., Démonet, J., Supiot, F., Rialland, A., Schmitz, D., Maison, P., Youssov, K. & Bachoud-Levi, A. (2015). Longitudinal study of informed consent in innovative therapy research: experience and provisional recommendations from a multicenter trial of intracerebral grafting. PloS one, 10(5), e0128209. doi:10.1371/journal.pone.0128209